Experts of the Pharmacoeconomics Department are leading a three-year EU4Health project “Capacity building to support the uptake of biosimilars in a multistakeholder approach” ( AUGMENT Biosimilars). The first year of the AUGMENT Biosimilars project focused on a comprehensive...
We aim to contribute to affordable, equitable and sustainable access to safe, effective and quality essential medicines in Austria, Europe and globally.
Biosimilar policies: New Evidence from 32 European countries
Updated PPRI Pharma Brief Germany published
The 2025 edition of PPRI Pharma Brief on Germany provides a comprehensive and up-to-date overview of the German pharmaceutical system, highlighting recent policy developments. This edition is complemented by a detailed flowchart and a list of key stakeholders. PPRI Pharma Briefa...
PPRI Network celebrates 20 years of international collaboration
On 15 - 16 September 2025, the PPRI Network celebrated its 20th anniversary in Vienna with a Network Meeting and the PPRI@20 Symposium, hosted by the Austrian National Public Health Institute (GÖG) and the Vienna Healthcare Group (WiGEV). Current network members, alumni, guest...